Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Taxifolin (Dihydroquercetin).
Taxifolin is a pentahydroxyflavanone that functions as a potent antioxidant and anti-inflammatory agent by modulating the Nrf2/HO-1 pathway and inhibiting pro-inflammatory cytokine production.
439533
304.25 g/mol
1.5
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Taxifolin (Dihydroquercetin) across standard consumer modalities.
Taxifolin is highly sensitive to oxidation and requires airtight encapsulation with an antioxidant stabilizer to prevent degradation of the phenolic rings.
The high melting point and potential for crystallization in aqueous pectin matrices can lead to a gritty texture and uneven distribution of the active flavonoid.
Payload capacity is severely limited due to the relatively high therapeutic dose required for systemic antioxidant effects, complicating the maintenance of film structural integrity.
Ready to launch a product featuring Taxifolin (Dihydroquercetin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Taxifolin (Dihydroquercetin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Taxifolin (Dihydroquercetin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation